[1] |
Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth [J]. Lancet, 2008, 371(9606): 75-84.
|
[2] |
Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data [J]. Am J Obstet Gynecol, 2018, 218(2): 161-180.
|
[3] |
Andersen HF, Nugent CE, Wanty SD, et a. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length [J]. Am J Obstet Gynecol, 1990, 163(3): 859-867.
|
[4] |
Rozenberg P. Universal cervical length screening for singleton pregnancies with no history of preterm delivery, or the inverse of the Pareto principle [J]. BJOG, 2017, 124(7): 1038-1045.
|
[5] |
Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery [J]. N Engl J Med, 1996, 334(9): 567-573.
|
[6] |
时春艳,张云燕,金燕志,等. 阴道超声测量子宫颈长度及宫颈管宽度对预测早产的价值[J]. 中华妇产科杂志,2003, 38(5): 264-266.
|
[7] |
曲首辉,时春艳,陈倩,等. 孕中、晚期孕妇子宫颈长度测量对早产的预测价值[J]. 中华妇产科杂志,2011, 46(10): 748-752.
|
[8] |
Maerdan M, Shi C, Zhang X, et al. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolongng of gestation [J]. J Matern Fetal Neonatal Med, 2017, 30(14): 1646-1649.
|
[9] |
Kuusela P, Jacobsson B, Söderlund, M, et al. Transvaginal sonographic evaluation of cervical length in the second trimester of asymptomatic singleton pregnancies, and the risk of preterm delivery [J]. Acta obstetricia et gynecologica Scandinavica, 2015, 94(6): 598-607.
|
[10] |
Fetal Medicine Foundation Cervical Assessment Certification [J/OL]. Available at: Accessed: February 8, 2016.
URL
|
[11] |
时春艳,杨慧霞,马京梅,等. 经阴道与经腹超声检测宫颈长度预测早产的价值[J]. 中国实用妇科与产科杂志,2009, 25(1): 40-42.
|
[12] |
Newnham JP, White SW, Meharry S, et al. Reducing preterm birth by a statewide multifaceted program: an implementation study [J]. Ultrasound Obstet Gynecol, 2017, 216(5): 434-442.
|
[13] |
Berghella V, Palacio M, Ness A, et al. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data [J]. Ultrasound Obstet Gynecol, 2017, 49(3): 322-329.
|
[14] |
Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials [J]. Am J Obstet Gynecol, 2016, 215(4): 431-438.
|
[15] |
Medley N, Poljak B, Mammarella S, et al. Clinical guidelines for prevention and management of preterm birth: a systematic review [J]. BJOG, 2018, 125(11): 1361-1369.
|
[16] |
Temming LA, Durst JK, Tuuli MG, et al. Universal cervical length screening: implementation and outcomes [J]. Am J Obstet Gynecol, 2016, 214(4): 523.e1-523.e8.
|
[17] |
Einerson BD, Grobman WA, Miller ES. Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth [J]. Am J Obstet Gynecol., 2016, 215(1): 100.e1-100.e7.
|
[18] |
Faron G, Balepa L, Parra J, et al. The fetal fibronectin test: 25 years after its development, what is the evidence regarding its clinical utility? A systematic review and meta-analysis [J]. J Matern Fetal Neonatal Med, 2018: 1-31.
|
[19] |
Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 130: prediction and prevention of preterm birth [J]. Obstet Gynecol, 2012, 120(4): 964-973.
|
[20] |
Esplin MS, Elovitz MA, Iams JD, et al. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women [J]. JAMA, 2017, 317(10): 1047-1056.
|
[21] |
Stock SJ, Wotherspoon LM, Boyd KA, et al. Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis [J]. BMJ open, 2018, 8(4): e020796.
|
[22] |
Melchor JC, Khalil A, Wing D, et al. Prediction of preterm delivery in symptomatic women using placental alpha-microglobulin-1, fetal fibronectin and phosphorylated insulin-like growth factor-binding protein-1 tests: systematic review and meta-analysis stratified by risk [J]. Ultrasound Obstet Gynecol, 2018, 52(4): 442-451.
|
[23] |
Eleje GU, Ezugwu EC, Eke AC, et al. Accuracy of a combined insulin-like growth factor-binding protein-1/interleukin-6 test (Premaquick) in predicting delivery in women with threatened preterm labor [J]. J Perinat Med, 2017, 45(8): 915-924.
|
[24] |
Polettini J, Cobo T, Kacerovsky M, et al. Biomarkers of spontaneous preterm birth: a systematic review of studies using multiplex analysis [J]. J Perinat Med, 2017, 45(1): 71-84.
|
[25] |
Holst RM, Hagberg H, Wennerholm UB, et al. Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids[J]. Obstet Gynecol, 2009, 114(2): 268-277.
|
[26] |
Tsiartas P, Holst RM, Wennerholm UB, et al. Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum [J]. BJOG, 2012, 119(7): 866-873.
|